4WT0 image
Entry Detail
PDB ID:
4WT0
Title:
Crystal structure of the DNA binding domains of LiaRD191N from E. faecalis
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2014-10-29
Release Date:
2015-05-06
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.24
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 2 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Response regulator receiver domain protein
Mutations:D191N
Chain IDs:A (auth: B), B (auth: A)
Chain Length:68
Number of Molecules:2
Biological Source:
Ligand Molecules
Primary Citation
A variable DNA recognition site organization establishes the LiaR-mediated cell envelope stress response of enterococci to daptomycin.
Nucleic Acids Res. 43 4758 4773 (2015)
PMID: 25897118 DOI: 10.1093/nar/gkv321

Abstact

LiaR is a 'master regulator' of the cell envelope stress response in enterococci and many other Gram-positive organisms. Mutations to liaR can lead to antibiotic resistance to a variety of antibiotics including the cyclic lipopeptide daptomycin. LiaR is phosphorylated in response to membrane stress to regulate downstream target operons. Using DNA footprinting of the regions upstream of the liaXYZ and liaFSR operons we show that LiaR binds an extended stretch of DNA that extends beyond the proposed canonical consensus sequence suggesting a more complex level of regulatory control of target operons. We go on to determine the biochemical and structural basis for increased resistance to daptomycin by the adaptive mutation to LiaR (D191N) first identified from the pathogen Enterococcus faecalis S613. LiaR(D191N) increases oligomerization of LiaR to form a constitutively activated tetramer that has high affinity for DNA even in the absence of phosphorylation leading to increased resistance. Crystal structures of the LiaR DNA binding domain complexed to the putative consensus sequence as well as an adjoining secondary sequence show that upon binding, LiaR induces DNA bending that is consistent with increased recruitment of RNA polymerase to the transcription start site and upregulation of target operons.

Legend

Protein

Chemical

Disease

Primary Citation of related structures